DRAWYUM PAIN RELIEF GEL-PATCH- lidocaine 4% pain relief gel-patch patch

DRAWYUM Pain Relief Gel-Patch by

Drug Labeling and Warnings

DRAWYUM Pain Relief Gel-Patch by is a Otc medication manufactured, distributed, or labeled by Jiangxi Yudexi Pharmaceutical Co., LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient

Lidocaine 4%

Purpose

Pain Relief

Use

▆temporarily relieves minor pain associated with: ▆arthritis ▆simple backache▆bursitis ▆tendonitis ▆muscle strains ▆sprains▆bruises ▆cramps

Warnings

For external use only

Do not use

▆use only as directed. Read and follow all directions and warnings on this carton. ▆avoid contact with eyes and mucous membranes ▆rare cases of serious burns have been reported with products of this type ▆ do not apply to wounds or damaged skin, broken or irritated skin ▆do not bandage tightly or apply local heat (such as heating pads) to the area of use ▆ A transient burning sensation may occur upon application but usually disappears within a few days.

When Using

▆use only as directed. Read and follow all directions and warnings on this carton. ▆avoid contact with eyes and mucous membranes ▆rare cases of serious burns have been reported with products of this type ▆ do not apply to wounds or damaged skin, broken or irritated skin ▆do not bandage tightly or apply local heat (such as heating pads) to the area of use ▆ A transient burning sensation may occur upon application but usually disappears within a few days.

Stop Use

▆condition worsens ▆redness is present ▆irritation develops▆symptoms persist for more than 7 days or clear up and occur again within a few dsys ▆you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied If pregnant or breast-feeding. ask a health professional before use

Ask Doctor

▆condition worsens ▆redness is present ▆irritation develops▆symptoms persist for more than 7 days or clear up and occur again within a few dsys ▆you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

Keep Oot Of Reach Of Children

Keep out of reach of children. lf swallowed, get medical help or contact a Poison Control Center right away

Directions

adults and children over 12 years. ▆remove backing from patch by firmly grasping both ends and gently pulling until backing separate in middle ▆carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area ▆once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area ▆Wear one patch for up to 8 hours. ▆Repeat if needed, but do not use more than 3 times daily. children 12 years or younger: ask a doctor

Inactive ingredients

water, aluminym hvdroxide, cellulose gum, glvcerin, isopropyl myristate, nonoxynol-30, polyacrylic acid,polysorbate 80, sodium polvacrvlate, sorbitan sesauioleate,Starch, talc, tartaric acid,titanium dioxide

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DRAWYUM PAIN RELIEF GEL-PATCH 
lidocaine 4% pain relief gel-patch patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85248-019
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	4 g  in 100

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
TARTARIC ACID (UNII: W4888I119H)
NONOXYNOL-30 (UNII: JJX07DG188)
SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)
POLYSORBATE 80 (UNII: 6OZP39ZG8H)
CELLULOSE GUM (UNII: K679OBS311)
GLYCERIN (UNII: PDC6A3C0OX)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
STARCH, CORN (UNII: O8232NY3SJ)
TALC (UNII: 7SEV7J4R1U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85248-019-01	20 in 1 PATCH; Type 0: Not a Combination Product	01/29/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	01/29/2026

Labeler - Jiangxi Yudexi Pharmaceutical Co., LTD (455662836)